Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Johnson & Johnson Innovation - JJDC, Inc.

Status
ACTIVE
Global HQ
New Brunswick, United States
Countries of investment
  • United States
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
  • Growth
Industries
  • Life Sciences
  • Pharma
About
Johnson & Johnson Innovation, JJDC, Inc. is the strategic venture arm of Johnson & Johnson, investing across pharmaceuticals, medical devices, consumer health, and digital health to accelerate innovation in human health.
Min check size
$100K
Max check size
$500K
Fund size
NPS

Investment Thesis

Johnson & Johnson Innovation, JJDC, Inc. is the strategic venture arm of Johnson & Johnson, investing in early- to growth-stage companies in pharmaceuticals, medical devices, and consumer health. It focuses on transformational science and breakthrough technologies that align with J&J’s global healthcare mission, providing capital, deep industry expertise, and commercialization resources to accelerate impact.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Johnson & Johnson Innovation JJDC, Inc. serves as the venture investment arm of Johnson & Johnson, backing healthcare startups globally, though public details on the specific experience of its managers are limited.

Johnson & Johnson Innovation - JJDC, Inc. Contacts Information

Primary contact

Secondary contact

Team

Irsa Ademi – Business Operations Manager

Lilian Alcaraz – VP Early Innovation Partnering (EMEA)

Janine Arts – Sr Director Oncology Scientific Innovation

Paul Ashley – Director Scientific Innovation (Data Sciences)

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp